Biotech leaders gather in San Sebastian for sold-out Bio€quity 2024

The great and the good of biotech descended on San Sebastian, Spain, for the influential Bio€quity Europe conference, one of the major dealmaking and networking events of the year.  Despite inclement weather, the conference was sold out, allowing CEOs and investors to gather, network, partner and debate issues facing the biotech industry.  Representatives of the […]

Optimum’s clients sunny perspective as summer approaches

From a major international investment event, to a new way to use the complement system to fight cancer, here’s what Optimum and its clients have been doing this week.  Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation join forces to accelerate global health equity and Novo Nordisk Foundation gives grants for global […]

Optimum and its clients push on as summer beckons

It’s May already, and Optimum Strategic Communications and its clients have had their foot on the gas this week as we head into the summer months. Poolbeg signs exclusive option agreement to acquire orphan drug candidate for Behçet’s Disease Poolbeg Pharma, a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases […]

Sector updates in April

Investment firms  Regeneron Pharmaceuticals launches Regeneron Ventures, committing USD $500 million to biotech investments over the next five years     Media     Gabrielle Masson has been promoted to Associate Editor at Fierce Biotech  Shelby Livingston has been appointed as Health Tech Reporter at Endpoints News  Brittany Trang has been appointed to Health Tech Reporter at STAT  […]

Optimum’s clients soak up the optimistic mood of 2024

The current optimistic mood in biotech was reflected in a string of positive announcements from Optimum and its clients.  SynOx completes $75m Series B financing to fund cancer mAb  SynOx Therapeutics Limited, the late-stage clinical biopharmaceutical company, on Monday announced the close of a $75m Series B financing. The financing was co-led by Forbion, HealthCap […]